HIMS & HERS HEALTH INC (HIMS)

US4330001060 - Common Stock

12.5  +0.23 (+1.87%)

After market: 12.61 +0.11 (+0.88%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to HIMS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 16.03. This target is 28.21% above the current price.
HIMS was analyzed by 18 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HIMS.
In the previous month the buy percentage consensus was at a similar level.
HIMS was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 12.5011.1116.3216.0321.00 - -11.12% 30.56% 28.21% 68.00%
Up and Down Grades
Date Firm Action Rating
2024-04-16 Jefferies Downgrade Buy -> Hold
2024-04-10 Canaccord Genuity Initiate Buy
2024-02-27 Guggenheim Maintains Buy -> Buy
2024-02-27 Truist Securities Maintains Hold -> Hold
2024-02-27 Piper Sandler Maintains Neutral -> Neutral
2024-02-27 Citigroup Maintains Buy -> Buy
2024-02-26 Leerink Partners Initiate Market Perform
2024-01-05 Tigress Financial Maintains Buy -> Buy
2023-08-09 Truist Securities Maintains Hold -> Hold
2023-08-08 Credit Suisse Reiterate Outperform -> Outperform
2023-07-28 TD Cowen Initiate Outperform
2023-06-15 Tigress Financial Reiterate Buy
2023-05-30 Piper Sandler Maintains Neutral -> Neutral
2023-05-09 B of A Securities Maintains Buy
2023-05-09 Piper Sandler Maintains Neutral
2023-04-27 Guggenheim Maintains Buy
2023-04-26 Piper Sandler Maintains Neutral
2023-04-11 Baird Initiate Neutral
2023-03-01 Credit Suisse Maintains Outperform
2023-02-28 Guggenheim Reiterate Buy
2023-02-28 Truist Securities Maintains Hold
2023-02-28 B of A Securities Maintains Buy
2023-02-28 Piper Sandler Maintains Neutral
2023-02-28 Citigroup Maintains Buy
2023-02-09 Jefferies Upgrade Hold -> Buy
2022-11-08 SVB Leerink Upgrade Underperform -> Market Perform
2022-11-08 B of A Securities Upgrade Neutral -> Buy
2022-10-17 Piper Sandler Downgrade Overweight -> Neutral
2022-09-07 Truist Securities Initiate Hold
2022-08-10 Credit Suisse Maintains Outperform